Status:
WITHDRAWN
Childhood Asthma Reduction Study
Lead Sponsor:
National Institute of Environmental Health Sciences (NIEHS)
Conditions:
Asthma
Eligibility:
All Genders
5-14 years
Phase:
NA
Brief Summary
Background: \- Cockroach allergies are an important risk factor for asthma in inner-city households, especially in children. A new method for killing cockroaches may help children who live in househo...
Detailed Description
Asthma is the most prevalent chronic childhood condition and is the most frequent cause of hospitalization among children. There are about 6.7 million children in the U.S. who currently have asthma, a...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- A child will be included in this study if the following criteria apply:
- (Assessed during phone screening)
- Aged 5 to 14 years of age
- Physician diagnosis of asthma for at least one year prior to prescreening
- Parent/guardian able and willing to provide consent; child able and willing to provide assent
- Primary caretaker and child are able to speak English or Spanish
- Moderate to severe asthma as defined by the child experiencing one of the following:
- One overnight hospitalization for asthma within the past 6 months,
- OR
- -Two unscheduled clinic or emergency department visits for asthma within the past 12 months
- Sleeps in the target home greater than or equal to 5 nights per week
- (Assessed at beginning of enrollment/baseline visit)
- Target home has greater than or equal to 30 cockroaches trapped in a 3 day period
- Positive ImmunoCAP Rapid test result to cockroach allergen
- EXCLUSION CRITERIA:
- A child will be excluded from this study if the following criteria apply, as determined in the screening phone call and/or confirmed at the baseline visit:
- The child has other serious medical or chronic illnesses, other than asthma, such as:
- Any hematologic, metabolic/endocrine, respiratory (other than asthma), cardiac or neurologic disorder requiring daily medications;
- Any severe behavioral problem that prohibits the child or the child s caregiver from answering questions or following instructions;
- Any autoimmune disease including rheumatoid arthritis, lupus, and myositis;
- Any immune deficiency;
- Any other serious medical condition such as juvenile diabetes mellitus, hypothyroidism, hyperthyroidism, cerebral palsy, hyperimmunoglobulin E syndrome, or diagnosed allergic bronchopulmonary aspergillosis.
- Plans to move within the 12 months of study enrollment
- Has no caregiver with access to a phone
- Sibling or other household member currently participating in the study.
Exclusion
Key Trial Info
Start Date :
September 4 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01468805
Start Date
September 4 2011
End Date
November 15 2013
Last Update
December 9 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.